algiax pharmaceuticals gmbh logo

Algiax Pharmaceuticals GmbH

Algiax Pharmaceuticals GmbH is an biotech company developing products in the field of nervous system disease or dysfunction with a special focus on neuropathic pai drug development.

No review box found! Insert a valid box ID.

KEY DETAILS

Websitehttp://algiax.de
Founded2011
Disease Focus
Development StagePreclinical
STOCK CODENon Listed
Address
Max-Planck-Str. 15a40699
Erkrath
Germany
Email
Contact Number
+49 211 617 851 0

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/algiax-pharmaceuticals” connections=”true” suffix=””]

In July 2014, Algiax raised 2.3 Mn Euro in Series B investment round for clinical development of AP-325. In 2012, it raised 4.3 Mn in Series A round from a consortium of investors including High-Tech Gr»nderfonds GmbH, KfW, Riesner Verwaltungs GmbH.